Eli Lilly Q4 Profit Misses, But Revenues Beat

Drug maker Eli Lilly and Co. on Tuesday reported a 61 percent increase in profit for the fourth quarter from last year, reflecting higher revenues and lower acquired in-process research and development charges. However, adjusted earnings per share for the quarter missed analysts' expectations, while revenues beat their estimates.

from RTT - Earnings http://ift.tt/2jQIcpW
via IFTTT